For over 70 years, Bioplus has served the pharmaceutical industry with high quality products, service, and technology. While continuing to build our global partnerships in Contract Manufacturing and EU / ANZ pharma generic pharmaceuticals, we are increasingly focused on utilizing our advanced skill set in Biotechnology. Today we are a late-stage clinical phase company with 2 programs for large global unmet needs both of which are Clinical phase 3 ready.
Our intention is to partner with leading companies regionally or globally to optimize product market access. We also have a rich pipeline of pre-clinical programs.
We expect the next 5 years to be of significant growth as our global block buster Novel therapeutics come to market. We continue to invest substantially in R&D and Clinical Development with supporting CAPEX in Capacity and Capability expansion. We are scientifically curious, focused on our targeted clinical development and are enjoying the journey to learn more and contribute to the health and well being of all global citizens.
From concept to logistics, our product development capability and global market knowledge gives us a long-term sustainable advantage. Additionally, our Bangalore Whitefield facilities are EU CGMP Certified with in-house laboratories.
|Tablets||7 Billion / Year|
|Capsules||630 Million / Year|
|Blend/ Powders||2000 Metric Tons / Year|
|Sachets||190 Million Sachets / Year|
|Liquids (2 Oz)||72 Million Bottles / Year|
|Liquids (17 Oz)||20 Million Bottles / Year|
|Effervescent||9.72 Million Tubes / Year|
|High Potency Tablets||100 million / Year|
|Peptides & Proteins||120 KGs / year|
|Synthetic Chemistry||1,20,000 Litres|
|Location||Site 1||Site 2||Site 3|
|Land Area||70,000 Ft2||70,000 Ft2||15 acres|
|Type||EU / TGA / Health Canada GMP Pharma-Solid oral dosage forms||Supplements- solid oral dosage forms||Liquid Dosage Form, R&D, F&D API / Biotech / Peptides|